Health Care/Hospital

P&G Health commemorates World Diabetes Day 2023 with innovative AI-based Experiential Campaign #KnowtheSigns

* 1 in 2 Diabetics and 1 in 10 Pre-diabetics estimated to suffer from Peripheral Neuropathy * Vitamin B Deficiency affects quality of life of ~ 19% of all people with diabetes * #KnowtheSigns leverages Artificial Intelligence to make the invisible condition of Peripheral Neuropathy & Vitami...

2023-11-01 14:00 1678

New 'One World, One Health' Report Shows Critical Need for Closer Collaboration Between Key Stakeholders Across Human, Animal, and Environmental Health

JPA Health Unveils Connectability Score to Measure Relationships Between Key Audiences WASHINGTON, Nov. 1, 2023 /PRNewswire/ -- A new report from JPA Health entitled, "One World, One Health: Exploring the Connectability between Human, Animal and Environmental Health," reveals a concerning lack o...

2023-11-01 12:01 1261

Extracellular Nanoparticles Sourced From Another Species Reverses Biological Age of Rats by More Than 50%

Peer Reviewed Publication: World's first demonstration of cross species epigenetic transfer that significantly reverses biological age by Scientists at Yuvan Research. MOUNTAIN VIEW, Calif., Nov. 1, 2023 /PRNewswire/ -- In a groundbreaking research paper titled"Reversal of Biological Age in Mult...

2023-11-01 09:14 991

Soterios Pharma completes Phase II enrolment for STS-01 in mild / moderate (patchy) alopecia areata

LONDON, Nov. 1, 2023 /PRNewswire/ -- Soterios Pharma, a privately held clinical-stage pharmaceutical company, announced today that it has completed target enrolment for its Phase II trial with STS-01 for mild / moderate (patchy) alopecia areata.  Final results of the study are anticipated to be ...

2023-11-01 09:05 896

Antengene Presents Results from Five Investigational Programs at 2023 SITC Annual Meeting

SHANGHAI and HONG KONG, Nov. 1, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer...

2023-11-01 08:30 1254

Complete Genomics demonstrates technical and commercial momentum in the sequencing market through new customers, partnerships and collaborations less than one year after launching in the U.S.

WASHINGTON, Oct. 31, 2023 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing company, announced today at the American Society of Human Genetics (ASHG) Annual Meeting,Nov. 1-5, in Washington details on the commercial and technical momentum it has demonstrated in the last 10 months ...

2023-10-31 21:44 1397

88th CMEF Unveils Cutting-Edge Medical Breakthroughs in Shenzhen, Unleashing the Latest Medical Technologies and Solutions

SHENZHEN, China, Oct. 31, 2023 /PRNewswire/ -- The 88th China International Medical Equipment Fair (CMEF) officially kicks off onOctober 28 at the Shenzhen World Exhibition & Convention Center. The four-day tradeshow will feature over 10,000 products brought by over 4,000 exhibitors from more tha...

2023-10-31 21:34 1707

BioLineRx Entered Exclusive License Agreement to Motixafortide in Asia, Advised by MSQ Ventures

NEW YORK, Oct. 31, 2023 /PRNewswire/ -- MSQ Ventures ("MSQ") is pleased to announce that its client, BioLineRx Ltd. ("BioLineRx") (NASDAQ/TASE: BLRX), has entered into an exclusive license agreement with Guangzhou Gloria Biosciences Co., Ltd. (GloriaBio) and an associated investor for the deve...

2023-10-31 21:00 2861

Lunit Joins as an Associate Partner with the World Economic Forum

- Lunit joins as an Associate Partner of the World Economic Forum, propelling global expansion and collaboration in the realm of AI-driven cancer care SEOUL, South Korea, Oct. 31, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and th...

2023-10-31 21:00 1373

YS Biopharma Announces Completion of Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine

GAITHERSBURG, Md., Oct. 31, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...

2023-10-31 20:30 1227

iba 2023: Angel Yeast brings latest baking products and solutions, empowering the China team to triumph in the iba.UIBC.Cup of Bakers

MUNICH, Oct. 31, 2023 /PRNewswire/ -- Premier global yeast company Angel Yeast (SH600298) recently presented its latest products and solutions at the iba 2023, theleading trade fair for the baking and confectionery industry, hosted from October 22 to 26 in Munich. ...

2023-10-31 20:00 2829

Meihua International Medical Technologies Co., Ltd. Establishes A Subsidiary Dedicated to Introducing International Patented Pharmaceuticals and Medical Device Technologies to China and Hainan Free Trade Port Boao Hope City

YANGZHOU, China, Oct. 31, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, announced today the establishme...

2023-10-31 20:00 2506

HOYA Vision Care Releases One-Year MiYOSMART European Study Results

Initial evidence-based findings of three-year study strongly supports MiYOSMART portfolio BANGKOK, Oct. 31, 2023 /PRNewswire/ -- HOYA Vision Care, committed to developing innovative solutions to address the growing problem of myopia progression in children, extended its research toEurope in an ...

2023-10-31 19:13 1425

CHIMERIC THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR CHM 2101, A NOVEL CDH17 CAR T CELL THERAPY FOR ADVANCED GASTROINTESTINAL CANCERS

* FDA IND Clearance for CHM 2101, a novel 3rd generation CDH17 CAR T cell therapy * Anticipated to be the first CDH17 CAR T cell therapy to enter the clinic * Phase 1A clinical trial to initiate patient enrolment in 2024 * Phase 1A clinical trial will enroll patients with advanced Colorecta...

2023-10-31 19:00 1079

Select the Right Medical-Grade TPU:ICP DAS - BMP Launches a New TPU Series at COMPAMED & IPF Japan 2023

HSINCHU, Oct. 31, 2023 /PRNewswire/ -- ICP DAS – Biomedical Polymers, Asia's first medical-grade TPU (thermoplastic polyurethane) manufacturer and supplier, will be exhibiting at COMPAMED inGermany and IPF in Japan in November and December 2023. The company proudly presents its new Arothane™ ARP-...

2023-10-31 16:38 1625

Osteopathy Australia and Exercise & Sports Science Australia express profound disappointment in the tokenistic NDIS (National Disability Insurance Scheme) review process

SYDNEY, Oct. 31, 2023 /PRNewswire/ -- Osteopathy Australia, the peak body representing osteopathic healthcare professionals and Exercise & Sports Science Australia (ESSA), the peak professional organisation representing tertiary-trained exercise and sports science practitioners, today voiced thei...

2023-10-31 15:57 1297

TCI Unveils Revolutionary Weight Loss Formula at SupplySide West 2023 - Human Trials Showcase Remarkable Effectiveness in Just 14 Days!

TAIPEI, Oct. 31, 2023 /PRNewswire/ -- In a groundbreaking debut at the esteemed SupplySide West 2023 event inLas Vegas, TCI introduced its revolutionary weight loss formula, backed by positive results from human clinical trials. This global exhibition, renowned for its focus on natural health in...

2023-10-31 15:54 1229

Biotechnology Start-Up Psylo Wins Hello Tomorrow APAC Deep Tech Competition in Singapore

SINGAPORE, Oct. 31, 2023 /PRNewswire/ -- Psylo, a biotechnology start-up pioneering the development of next-generation serotonergic agents for the treatment of central nervous system (CNS) disorders, today announced that it won the Hello Tomorrow APAC deep tech competition held inSingapore. The ...

2023-10-31 15:42 1425

Embrace Exquisite Living with Innovative Personal Care Products at the 134th Canton Fair

GUANGZHOU, China, Oct. 31, 2023 /PRNewswire/ -- At Phase 3 of the 134th Canton Fair onsite, heldbetween October 31st and November 4th, "Personal Care Products" exhibition section has been rescheduled from Phase 2 to 3, emerging as a major highlight. Spanning an expansive area of around 11,000 squ...

2023-10-31 15:17 1623

iNtRON, Executes Evaluation License and Option Agreement for SAL200

* iNtRON Grants Basilea exclusive right for preclinical evaluation with an undisclosed payment * Basilea has the option to enter into exclusive License Agreement following the evaluation BOSTON and SEOUL, South Korea, Oct. 30, 2023 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON",www.intodeworl...

2023-10-31 12:20 1120
1 ... 78798081828384 ... 808